Pro Retina Stiftung

Stiftung zur Verhütung von Blindheit

Service-Navigation
 
Inhalt
Sie sind hier:

Friday, March 22, 2019

13:00 - 13:05 Welcome remarks
Franz Badura, Amberg

13:05 - 14:30 SESSION 1
Selected poster presentations
Eight abstracts to be selected

14:30 - 15:00 Keynote lecture
Rando Allikmets, New York
Selecting patients for clinical trials based on their specific mutations

15:00 - 15:45 Coffee break

15:45 - 17:25 SESSION 2
Molecular diagnostics and gene therapy in retinal dystrophy

15:45 - 16:10 Susanne Roosing, Nijmegen
Diagnostic and research explorations of WES and WGS for retinal diseases

16:10 - 16:35 Lisa-Marie Dürr, Regensburg
Identification of an FDA-approved compound correcting pathology of Best vitelliforme macular dystrophy

16:35 - 17:00 Dominik Fischer, Tübingen
Achromatopsia CNG3B clinical trial

17:00 - 17:25 Alex Garanto, Nijmegen
Critical assessment of gene therapy

17:30 Dinner

19:00 - 20:00 EVENING LECTURE
Birgit Lorenz, Gießen
RPE65 deficiency. Challenges in diagnosis and treatment

20:00 - open Swingin' poster session

Saturday, March 23, 2019

09:00 - 10:40 SESSION 3
Retina chip and optogenetics

09:00 - 09:25 Katarina Stingl, Tübingen
State of the art and expectations of retina chips

09:25 - 09:50 Daniel Rathbun, Tübingen

Form vision: How good can retina chips actually get

09:50 - 10:15 Jens Dübel, Paris

Optogenetics meets cell replacement - a synergystic approach to repair retinal structure and function

10:15 - 10:40 Volker Bußkamp, Dresden

The potential of optogenetic rhodopsin channels

10:40 - 11:15 Coffee break

11:15 - 12:55 SESSION 4
Cell substitution in retinal dystrophy

11:15 - 11:40 Henry Klassen, Irvine

Stem cell therapy for RP: Launching a phase IIb clinical trial

11:40 - 12:05 Marius Ader, Dresden

Photoreceptor replacement therapy - pros and cons

12:05 - 12:30 Slaven Erceg, Valencia
iPS cell-derived RPE in disease development and cell therapy. And what about phtoreceptors?

12:30 - 12:55 Boris Stanzel, Sulzbach
RPE cell therapeutics: How do you actually get them from the lab into a patient?

12:55 - 13:00 Concluding remarks

13:00 Lunch and end of meeting
Aktuelles

Bitte unterstützen Sie unsere Arbeit mit Ihrer Spende!

Jeder Euro hilft. Weitere Informationen finden Sie auf der Seite: Spenden an die Pro-Retina-Stiftung

Newsletter

Abonnieren Sie unseren Newsletter PRO RETINA News!


© 2010 - 2018 - PRO RETINA-Stiftung zur Verhütung von Blindheit

Datenschutzerklärung